Prescription drug · ANDA
Famciclovir NDC 73190-092
Famciclovir 250 mg/1 · Tablet, Film coated · Oral · AvKARE
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73190-092-30 | 73190009230 | 30 TABLET, FILM COATED in 1 BOTTLE (73190-092-30)Marketed from Jul 21, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Famciclovir
- Generic name (nonproprietary)
- famciclovir
- Active ingredients
- Famciclovir — 250 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- AvKARE
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202438
- Marketing start
- Listing expires
- Other FDA classes
- DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
- Identifiers
- Product ID 73190-092_5723f51d-d8b3-2a59-e063-6394a90a9328SPL ID 5723f51d-d8b3-2a59-e063-6394a90a9328SPL set ID 5723f50e-b0fa-65f0-e063-6294a90a350fRxCUI 198382, 199192, 199193UNII QIC03ANI02
- Pharmacologic class
- Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473190009230followed by a unit qualifier and the quantityPackage 73190-0092-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Famciclovir tablet, a prodrug of penciclovir, is a deoxynucleoside analog DNA polymerase inhibitor indicated for: Immunocompetent Adult Patients ( 1.1 ) • Herpes labialis (cold sores) o Treatment of recurrent episodes • Genital herpes o Treatment of recurrent episodes o Suppressive therapy of recurrent episodes • Herpes zoster (shingles) Human Immunodeficiency Virus (HIV)-Infected Adult Patients ( 1.2 ) • Treatment of recurrent episodes of orolabial or genital herpes Limitation of Use The efficacy and safety of famciclovir tablets have not been established for: • Patients with first episode of genital herpes • Patients with ophthalmic zoster • Immunocompromised patients other than for the tr…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 202438
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Famciclovir | Famciclovir 125 mg/1 | Tablet, Film coatedOral | AvKARE | 73190-091 |
| Famciclovir | Famciclovir 500 mg/1 | Tablet, Film coatedOral | Proficient Rx LP | 63187-998 |
| Famciclovir | Famciclovir 500 mg/1 | Tablet, Film coatedOral | AvKARE | 73190-093 |
| Famciclovir | Famciclovir 500 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-7890 |
| Famciclovir | Famciclovir 125 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-706 |
| Famciclovir | Famciclovir 250 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-707 |
| Famciclovir | Famciclovir 500 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-708 |